Pitfalls and Progress in the Development of Immune Stimulatory Nucleic Acids
Date: June 2, 2022 Time: 11-12 EST Speaker: Art Krieg, MD, Checkmate Pharmaceuticals Description: Art Krieg, MD, CSO at Checkmate Pharmaceuticals, focuses his research on stimulating innate immunity with immune stimulatory DNA and RNA. Join us as Dr. Krieg discusses the history of efforts ...
Trainee Spotlight Series: Tom Metz and Briana Wilson
Date: May 19, 2022 Time: 11-12 EST, 5-6 CET Description: This Trainee Spotlight features Tom Metz and Briana Wilson. Tom Metz is a Ph.D. candidate at Leiden University Medical Center (LUMC). Tom will present his work involving the biodistribution of a radioactively labelled AON ...
Trainee Spotlight Series: Jakob Jung and Sara Overby
Date: April 21, 2022 Time: 11-12 EST, 5-6 CET Description: In our first of many Trainee Spotlights, we feature Jakob Jung and Sarah Overby. Jakob Jung is a Ph.D. candidate at the Institute for Molecular Infection Biology (IMIB), at the University of Würzburg. ...
Chemical and Nanotechnology-based Approaches to Build Next-gen Oligonucleotide Therapeutics
Join Aurélie Lacroix, PhD and Leonora Abdullahu, PhD, the 2021/2022 OTS Trainee Reps, as they share about their research and career paths. Speaker: Aurélie Lacroix, PhD, Senior Scientist / MSCA fellow, Sixfold Bioscience Bio ...
Antisense Oligonucleotide-based Therapies for Inherited Retinal Diseases: From Mutation to Clinical Trial
Speaker: Alex Garanto, PhD Date: March 10, 2022 Time: 11-12 EST Description: The eye is at the forefront of therapeutic development for its unique properties. Local delivery of ASOs to the retina has shown to be well tolerated and safe. During this webinar, Prof. ...
Meet Your 2022 OTS Trainee Reps
Speaker: Chantal Ferguson, MD, PhD Candidate and Hassan Fakih, PhD Date: February 24, 2022 Time: 11-12 EST Description: The OTS values and encourages the contribution of trainees to the society. The trainee representative to the Board of Directors position was created to give trainees ...
A Perspective From Industry – A Conversation With Richard S. Geary, Ph.D. Executive Vice President, Chief Development Officer at Ionis Pharmaceuticals
Speaker: Richard S. Geary, Ph.D. Date: February 10, 2022 Time: 11-12 EST Description: The OTS Webinar series is pleased to feature Dr. Richard Geary, the current President Elect, and the Executive Vice President, Chief Development Officer at Ionis Pharmaceuticals. For part of the webinar ...
A Conversation with OTS President, Prof. David Corey
Speaker: David Corey, Ph.D. Date: January 13, 2022 Time: 11-12 EST Description: Join us for an open discussion on the future of the OTS. Prof. David Corey will share his vision for, and answer questions about the OTS. Hosted by former trainee reps, Ronald ...
Development of N=1 RNA Therapies in the Netherlands and Europe
After the development of Milasen in the United States, there has been an increase in the development of antisense oligonucleotide therapies for patients with unique mutations.
2021 OTS Annual Meeting Poster Winner Showcase
Date: October 29th, 2021 Time: 7am-9am Pacific/ 10am-12pm Eastern/ 4pm-6pm Central European Time Description: Are you having post-event letdown now that the annual OTS meeting is over? We are too! Join us for this special 2-hour webinar to see presentations by four poster award ...
